Carmichael Hill & Associates Inc. Has $87,000 Stake in The Allstate Co. (NYSE:ALL)

Carmichael Hill & Associates Inc. increased its stake in shares of The Allstate Co. (NYSE:ALL) by 15.0% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 460 shares of the insurance provider’s stock after acquiring an additional 60 shares during the period. Carmichael Hill & Associates Inc.’s holdings in Allstate were worth $87,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Northwest Investment Counselors LLC bought a new stake in Allstate during the 3rd quarter valued at approximately $28,000. Versant Capital Management Inc boosted its stake in Allstate by 70.9% during the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 78 shares during the period. Family Firm Inc. bought a new stake in Allstate during the 2nd quarter valued at approximately $38,000. MCF Advisors LLC boosted its stake in Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after purchasing an additional 84 shares during the period. Finally, First Command Advisory Services Inc. bought a new stake in Allstate during the 2nd quarter valued at approximately $58,000. Institutional investors and hedge funds own 76.47% of the company’s stock.

Insider Activity at Allstate

In other news, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the sale, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the sale, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 192,530 shares of company stock valued at $34,967,665 in the last three months. Corporate insiders own 1.80% of the company’s stock.

Allstate Trading Down 1.3 %

ALL stock opened at $184.15 on Friday. The business has a fifty day moving average price of $188.87 and a 200 day moving average price of $175.23. The Allstate Co. has a fifty-two week low of $127.93 and a fifty-two week high of $198.79. The stock has a market capitalization of $48.62 billion, a price-to-earnings ratio of 11.93, a P/E/G ratio of 1.91 and a beta of 0.48. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 27.74% and a net margin of 6.77%. The firm had revenue of $16.63 billion during the quarter, compared to analysts’ expectations of $14.57 billion. During the same period last year, the firm posted $0.81 EPS. The business’s revenue was up 14.7% on a year-over-year basis. Analysts expect that The Allstate Co. will post 14.16 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. TD Cowen increased their target price on Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a research note on Tuesday, September 3rd. Piper Sandler raised their price objective on Allstate from $188.00 to $196.00 and gave the stock an “overweight” rating in a research report on Friday, August 16th. The Goldman Sachs Group raised their price objective on Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a research report on Thursday, August 15th. UBS Group raised their price objective on Allstate from $215.00 to $216.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Finally, Barclays raised their price objective on Allstate from $175.00 to $187.00 and gave the stock an “underweight” rating in a research report on Thursday. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $207.19.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.